Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
6 trials
Recent
Start date
Enrollment
Phase 2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Clear all
Filters
3
NCT04428151
2025-12-04
LEAP-009
Merck Sharp & Dohme LLC
Phase 2
Completed
408 enrolled
17 charts
NCT04704219
2025-12-03
KEYNOTE-B61
Merck Sharp & Dohme LLC
Phase 2
Completed
160 enrolled
14 charts
NCT03797326
2025-11-17
LEAP-005
Merck Sharp & Dohme LLC
Phase 2
Completed
611 enrolled
27 charts
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled
NCT04924101
2025-07-23
KEYNOTE-B99
Merck Sharp & Dohme LLC
Phase 2
Completed
126 enrolled
NCT03516981
2025-07-01
MK-3475-495
Merck Sharp & Dohme LLC
Phase 2
Completed
245 enrolled